• locale

  United States

• market

  PRIVATE

• industry

  Biotechnology

• website

  www.crescentabio.com

Crescenta Biosciences II develops immunometabolic modulators for treating age-related diseases and cancer. The company focuses on modulating the immune response by targeting biological functions associated with lipid binding proteins.